mortality/aging
|
• median age of death is 4.5 months
|
neoplasm
|
• 23% of mice develop osseous metaplasia
|
|
• one mouse developed lymphosarcoma
|
|
• in 8% of mice with metastasis to the liver
|
|
• 85% of mice develop peripheral nerve tumors
|
|
• 8% of mice develop neurofibroma
|
|
• 77% of mice develop peripheral nerve tumors from peripheral nerves of the limbs and from the dorsal root ganglia
|
|
• 11% of mice develop schwannoma
|
skeleton
|
• 35% of mice exhibit odontoblastic hyperplasia
|
|
• 15% of mice develop osteogenic hyperplasia
|
nervous system
|
• 81% of mice exhibit Schwann cell hyperplasia with increased incidence of diffuse Schwann cell hyperplasia in major peripheral nerve trunks
|
|
• 85% of mice develop peripheral nerve tumors
|
|
• 8% of mice develop neurofibroma
|
|
• 77% of mice develop peripheral nerve tumors from peripheral nerves of the limbs and from the dorsal root ganglia
|
|
• 11% of mice develop schwannoma
|
renal/urinary system
|
• 73% of mice exhibit renal tubular cell hyperplasia
|
vision/eye
craniofacial
|
• 35% of mice exhibit odontoblastic hyperplasia
|
growth/size/body
|
• 35% of mice exhibit odontoblastic hyperplasia
|
muscle
|
• in 8% of mice with metastasis to the liver
|
cellular
|
• 81% of mice exhibit Schwann cell hyperplasia with increased incidence of diffuse Schwann cell hyperplasia in major peripheral nerve trunks
|


Analysis Tools